Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

80856 ARTÍCULOS , VIENDO DEL 1 AL 15

Case Report: Electroencephalography-informed low-frequency repetitive transcranial magnetic stimulation targeting the supplementary motor area in severe functional movement disorder

Takahashi C, Asahi T, Kanda M, Ohta Y, Matsushita I.

Front Psychiatry. 2026 Oct 16;17:1959751. doi: 10.3389/fpsyt.2026.1959751. eCollection 2026.

Spatial Neurophysiological Gradients at High Resolution Differentiate Tumor Types in the Human Cortex at the Tumor-Brain Interface

Nelson T, Hsueh B, Hadar P, Das I, Coughlin BF, Mandal AS, Wilson T, Peng E, Perley AS, Rabbani H, Ciordia R, Zou J, Bush A, Vissani M, Ghaith H, Cahill J, Yang JC, Muñoz W, Torio E, Glaser AC, Bernstock JD, Collins KL, Cleary DR, Tiwana HK, Golby AJ, Jones PS, Choi BD, Nahed BV, Raslan AM, Williams ZM, Dayeh SA, Nanda P, Richardson RM, Bi WL, Tobochnik S, Cahill DP, Dunn GP, Cash SS, Paulk AC.

medRxiv [Preprint]. 2026 Oct 7:2026.10.05.26364665. doi: 10.64898/2026.10.05.26364665.

Clinical improvement despite rising anti-streptococcal antibody titers during adjunctive bacteriophage therapy in refractory PANDAS: a hypothesis-generating case report

Recordare A, Dadiani M, Nizharadze D, Nadareishvili L, Pirozzolo G, Palumbo R, Girotto C, Mezzapelle G, Kutateladze M.

Front Med (Lausanne). 2026 Oct 19;13:1973954. doi: 10.3389/fmed.2026.1973954. eCollection 2026.

Engineered peroxisomes and patient-derived iPSC models as potential biomaterial platforms for precision neuroprotection in oxidative stress-driven central nervous system disorders

Matta C, Cheon YH, Vágó J, Mészár Z, Kim EH, Jiang S, Balogh A, Zana M, Dinnyés A, Jin EJ.

Mater Today Bio. 2026 Oct 13;41:103752. doi: 10.1016/j.mtbio.2026.103752. eCollection 2026 Dec.

Effects of eating behavior patterns and dietary habits on the therapeutic efficacy of Parkinson's disease medications: from phenomena, mechanisms to clinical applications

Ye J, Zhang SJ, Guan J, Shen ZH, Wang J, Yang R, Huang M, Li ZM, Lin Y, Gan H, Wu S, Wang Y, Yang K.

Front Nutr. 2026 Oct 19;13:1969279. doi: 10.3389/fnut.2026.1969279. eCollection 2026.

Manganese Deposition Encephalopathy Associated With Prolonged Total Parenteral Nutrition: A Case Report

Zanardo Faggion B, Vicenzi Souza LA, Beluzzo da Mota de Lima Sinke G, Collaço de Oliveira Valente R.

Cureus. 2026 Sep 30;18(9):e117250. doi: 10.7759/cureus.117250. eCollection 2026 Sep.

Modulating neuroinflammation with glucagon-like peptide-1 receptor agonists: a scoping review exploring their therapeutic potential in schizophrenia

Otto B, Zantvoord JB, Siskind D, Vermeulen JM.

Prog Neuropsychopharmacol Biol Psychiatry. 2026 Oct 2;150:111978. doi: 10.1016/j.pnpbp.2026.111978. Epub 2026 Oct 17.

Immunometabolic dysregulation of reactive microglia and astrocytes in neurodegenerative diseases: Mechanistic insights and therapeutic implications

Gao C, Shi R, Jiang X, Chai H, He X.

J Neurol Sci. 2026 Oct 28;491:126237. doi: 10.1016/j.jns.2026.126237. Online ahead of print.

Photobiomodulation as a regulator of neuroinflammation: mechanistic insights and therapeutic potential in brain disorders

Blivet G, Bertrand C, Brauge D, Delrieu J, Touchon J.

Front Neurol. 2026 Oct 16;17:1902491. doi: 10.3389/fneur.2026.1902491. eCollection 2026.

From dosage alteration to amplification strategies: mechanistically defined alpha-synuclein mouse models for Parkinson's disease therapy development

Nuber S, Fanning S, Dettmer U.

Acta Neuropathol. 2026 Oct 30;152(1):65. doi: 10.1007/s00401-026-03112-4.

Nutritional education program counseling based on the Mediterranean diet on intestinal constipation in people with Parkinson's disease: a randomized clinical trial

Fernandez RD, da Silva Mesquita F, Ferreira GC, Santos-Lobato BL.

Parkinsonism Relat Disord. 2026 Nov;152:109003. doi: 10.1016/j.parkreldis.2026.109003. Epub 2026 Sep 28.

The Emerging Role of α-Synuclein Strains in Parkinson's Disease: From Molecular Pathology to Clinical Phenotypes

Verma A, Tiwari PC, Sharma B, Bihari B, Pal R.

Cureus. 2026 Oct 1;18(10):e117292. doi: 10.7759/cureus.117292. eCollection 2026 Oct.

The metabolic-brain axis: GLP-1 signaling, insulin resistance, and obesity pharmacotherapy in neurodegeneration

Santerre M, Shcherbik N, Sawaya BE.

Metabolism. 2026 Oct 30:156810. doi: 10.1016/j.metabol.2026.156810. Online ahead of print.

Nanotechnology-enabled Bromocriptine Delivery for Parkinson's Disease: Overcoming Pharmacokinetic Barriers and Advancing Brain Targeting

Sanshita, Kaur J, Ray A, Chakraborty S, Singh I.

Ann Pharm Fr. 2026 Oct 30:S0003-4509(26)00172-0. doi: 10.1016/j.pharma.2026.10.006. Online ahead of print.

Ceruloplasmin in Disorders of the Nervous System

Pourhadi M, LeWitt PA, Todi SV.

Aging Dis. 2026 Oct 20. doi: 10.14336/AD.2026.0988. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias